<DOC>
	<DOCNO>NCT01643772</DOCNO>
	<brief_summary>A Single Dose PK Study OxyNorm® immediate-release capsule 5 , 10 , 20mg , multiple-dose PK Study OxyNorm® immediate-release capsule 10mg Chinese patient pain.It single center , open label , randomize , oral administration study .</brief_summary>
	<brief_title>OxyNorm® Capsules ( Immediate-Release ) Pharmacokinetic ( PK ) Study</brief_title>
	<detailed_description>Single dose : The subject randomize receive single dose OxyNorm® immediate-release capsule 5 , 10 , 20mg . Multiple dose : The subject take 3 day OxyNorm® capsule 10mg , every 6 hour , 10mg per dose . In morning 4th day , subject take single dose OxyNorm® capsule 10mg . On 5th day , subject complete study .</detailed_description>
	<mesh_term>Oxycodone</mesh_term>
	<criteria>Patients pain , Multiple dose group enroll Patients cancer pain ; Patients age &gt; ≥30 ≤ 60 year ; Body weight ≥ 45kg , BMI range ≥19 , &lt; 24 ; Karnofsky score ≥ 70 ; The result liver function kidney test must meet following criterion : ALT、AST within upper limit normal value range factor 2 , TB、BUN、Cr within upper limit normal value range factor 1.25 ; The electrocardiogram examination result normal ; Patients must give write informed consent prior trial , capability complete every required test . Have hypersensitivity history opioids ; Have know hypersensitivity composition study drug ; Patients likely paralytic ileus acute abdomen perform operation abdominal region； Patients respiratory depression , cor pulmonale , chronic bronchial asthma ; Patients unable stop take monoamine oxidase inhibitor trial period time lapse less 2 week since drug withdrawal ; Patients hypercarbia ; Patients biliary tract disease , pancreatitis , prostatic hypertrophy , corticoadrenal insufficiency ; Patients alcoholism drug abuse history ; Positive antiHIV syphilis antibody test result ; Patients pregnant , lactate ; Urine screen study positive opioids , barbiturate , amphetamine , cocaine metabolite , methadone , diazepam cannabinoids ; Donated 400 mL blood blood product within 3 month prior start study , donate 200 mL blood blood product within one month prior start study ; Subjects participate clinical research study within one month study entry ; Patients currently take opioids .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>